Dai-ichi Life Insurance Company’s Charles River Laboratories CRL Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,430	Closed	-$449K	–	487
2024 Q4	$449K	Hold	2,430	–	–	0.01%	458
2024 Q3	$479K	Sell	2,430 -1,000	-29%	-$208K	0.01%	460
2024 Q2	$709K	Sell	3,430 -6,000	-64%	-$1.36M	0.02%	401
2024 Q1	$2.56M	Hold	9,430	–	–	0.06%	270
2023 Q4	$2.23M	Sell	9,430 -17,850	-65%	-$3.51M	0.05%	288
2023 Q3	$5.35M	Sell	27,280 -1,764	-6%	-$362K	0.12%	159
2023 Q2	$6.11M	Buy	29,044 +3,350	+13%	+$667K	0.13%	146
2023 Q1	$5.19M	Sell	25,694 -14,000	-35%	-$3.17M	0.11%	170
2022 Q4	$8.65M	Hold	39,694	–	–	0.2%	102
2022 Q3	$7.81M	Hold	39,694	–	–	0.19%	106
2022 Q2	$8.49M	Buy	39,694 +194	+0.5%	+$47.4K	0.19%	105
2022 Q1	$11.2M	Buy	39,500 +2,000	+5%	+$617K	0.18%	117
2021 Q4	$14.1M	Buy	37,500 +9,500	+34%	+$3.69M	0.18%	108
2021 Q3	$11.6M	Hold	28,000	–	–	0.15%	124
2021 Q2	$10.4M	Buy	28,000 +8,000	+40%	+$2.67M	0.13%	141
2021 Q1	$5.8M	Buy	+20,000	New	+$5.56M	0.08%	190

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dai-ichi Life Insurance Company's CRL Position: Q1 2025 in Review

Dai-ichi Life Insurance Company sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 2,430 shares — an estimated $449K sold.

Dai-ichi Life Insurance Company first reported a position in CRL in Q1 2021 and held it in 16 quarters. The position peaked at $14.1M in Q4 2021. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

Dai-ichi Life Insurance Company reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
Dai-ichi Life Insurance Company sold 2,430 Charles River Laboratories shares in Q1 2025, an estimated $449K.
Dai-ichi Life Insurance Company first reported a position in Charles River Laboratories in Q1 2021 and held it in 16 quarters.
Dai-ichi Life Insurance Company's Charles River Laboratories position peaked at $14.1M in Q4 2021.
561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2025, filed 15 May 2025.